A 36-Week Extension to Protocol ISA04-03 to Evaluate the Safety and Efficacy of ISA247 in Patients With Plaque Psoriasis [Extension of profile 700036436]

Trial Profile

A 36-Week Extension to Protocol ISA04-03 to Evaluate the Safety and Efficacy of ISA247 in Patients With Plaque Psoriasis [Extension of profile 700036436]

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Voclosporin (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions
  • Sponsors Aurinia Pharmaceuticals
  • Most Recent Events

    • 01 Apr 2014 New trial record
    • 30 Jan 2007 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top